VTv Price Earnings To Growth Ratio from 2010 to 2024

VTVT Stock  USD 15.51  0.09  0.58%   
VTv Therapeutics Price Earnings To Growth Ratio yearly trend continues to be comparatively stable with very little volatility. Price Earnings To Growth Ratio will likely drop to 0.04 in 2024. From the period from 2010 to 2024, VTv Therapeutics Price Earnings To Growth Ratio quarterly data regression had mean square error of  0.12 and mean deviation of  0.16. View All Fundamentals
 
Price Earnings To Growth Ratio  
First Reported
2010-12-31
Previous Quarter
0.04616062
Current Value
0.0439
Quarterly Volatility
0.33799565
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check VTv Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among VTv Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 85.5 K, Interest Expense of 12.3 K or Selling General Administrative of 11.5 M, as well as many indicators such as Price To Sales Ratio of 27.56, Dividend Yield of 0.0 or Days Sales Outstanding of 2 K. VTv financial statements analysis is a perfect complement when working with VTv Therapeutics Valuation or Volatility modules.
  
Check out the analysis of VTv Therapeutics Correlation against competitors.
For more information on how to buy VTv Stock please use our How to Invest in VTv Therapeutics guide.

Latest VTv Therapeutics' Price Earnings To Growth Ratio Growth Pattern

Below is the plot of the Price Earnings To Growth Ratio of vTv Therapeutics over the last few years. It is VTv Therapeutics' Price Earnings To Growth Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in VTv Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Price Earnings To Growth Ratio10 Years Trend
Pretty Stable
   Price Earnings To Growth Ratio   
       Timeline  

VTv Price Earnings To Growth Ratio Regression Statistics

Arithmetic Mean0.12
Coefficient Of Variation273.59
Mean Deviation0.16
Median0.09
Standard Deviation0.34
Sample Variance0.11
Range1.4694
R-Value(0.14)
Mean Square Error0.12
R-Squared0.02
Significance0.63
Slope(0.01)
Total Sum of Squares1.60

VTv Price Earnings To Growth Ratio History

2024 0.0439
2023 0.0462
2022 -0.13
2021 -0.0688
2020 0.13
2019 -0.17
2018 0.0674

About VTv Therapeutics Financial Statements

VTv Therapeutics shareholders use historical fundamental indicators, such as Price Earnings To Growth Ratio, to determine how well the company is positioned to perform in the future. Although VTv Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in VTv Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on VTv Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Price Earnings To Growth Ratio 0.05  0.04 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for VTv Stock Analysis

When running VTv Therapeutics' price analysis, check to measure VTv Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VTv Therapeutics is operating at the current time. Most of VTv Therapeutics' value examination focuses on studying past and present price action to predict the probability of VTv Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VTv Therapeutics' price. Additionally, you may evaluate how the addition of VTv Therapeutics to your portfolios can decrease your overall portfolio volatility.